3L3L | Transferase Transferase Inhibitor | date | Dec 17, 2009 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Parp Complexed With A906894 | ||||||||||||||
authors | C.H.Park | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Poly [Adp-Ribose] Polymerase 1 Chain: A Fragment: Residues 662-1011 Synonym: Parp-1, Adprt, Nad(+) Adp-Ribosyltransferase 1, Po Ribose] Synthetase 1; Ec: 2.4.2.30 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Parp1, Adprt, Ppol Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 3 2 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.50 Å | ||||||||||||
ligand | L3L BindingDB | enzyme | Transferase E.C.2.4.2.30 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery and SAR of substituted 3-oxoisoindoline-4-carboxamides as potent inhibitors of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer., Gandhi VB, Luo Y, Liu X, Shi Y, Klinghofer V, Johnson EF, Park C, Giranda VL, Penning TD, Zhu GD, Bioorg Med Chem Lett. 2010 Feb 1;20(3):1023-6. Epub 2009 Dec 14. PMID:20045315 |
Data retrieval |
View 3L3L in 3D |
Visual 3D analysis of 3L3L |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3L3L |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |